DA
Dickinson Andrew D Chief Financial Officer
CFO M
US US · SEC (Form 4)
Explore the full record of transactions filed by Dickinson Andrew D, Chief Financial Officer. Insider active across 2 companies, notably Gilead Sciences, INC.. Aggregated, 29 reports have been logged. Total volume traded: €5m. The latest transaction was disclosed on 15 April 2026 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations 29 total
US$358,095 3,000 shares @ US$119.3649 0.0002% mcap 14.3% of flow
Common Stock
SEC:0001310204-26-000014 · 15 Apr 2026
€358,095 3,000 shares @ €119.3649 0.0002% mcap 7.1% of flow
Common Stock
SEC:0001310204-26-000014:0 · 15 Apr 2026
US$378,387 3,000 shares @ US$126.1291 0.0002% mcap 15.1% of flow
Common Stock
SEC:0001310204-26-000012 · 16 Mar 2026
€378,387 3,000 shares @ €126.1291 0.0002% mcap 7.5% of flow
Common Stock
SEC:0001310204-26-000012:0 · 16 Mar 2026
US$390,966 3,000 shares @ US$130.3219 0.0002% mcap 15.6% of flow
Common Stock
SEC:0001310204-26-000006 · 17 Feb 2026
€390,966 3,000 shares @ €130.3219 0.0002% mcap 7.8% of flow
Common Stock
SEC:0001310204-26-000006:0 · 17 Feb 2026
US$320,213 3,000 shares @ US$106.7375 0.0002% mcap 12.8% of flow
Common Stock
SEC:0001310204-26-000002 · 15 Jan 2026
€320,213 3,000 shares @ €106.7375 0.0002% mcap 6.4% of flow
Common Stock
SEC:0001310204-26-000002:0 · 15 Jan 2026
US$311,817 3,000 shares @ US$103.9391 0.0002% mcap 12.4% of flow
Common Stock
SEC:0001310204-25-000021 · 15 Dec 2025
€311,817 3,000 shares @ €103.9391 0.0002% mcap 6.2% of flow
Common Stock
SEC:0001310204-25-000021:0 · 15 Dec 2025
US$253,471 2,500 shares @ US$101.3882 0.0002% mcap 10.1% of flow
Common Stock
SEC:0001310204-25-000014 · 15 Oct 2025
€253,471 2,500 shares @ €101.3882 0.0002% mcap 5.0% of flow
Common Stock
SEC:0001310204-25-000014:0 · 15 Oct 2025
US$241,356 2,500 shares @ US$96.5424 0.0002% mcap 9.6% of flow
Common Stock
SEC:0001310204-25-000011 · 15 Sept 2025
€241,356 2,500 shares @ €96.5424 0.0002% mcap 4.8% of flow
Common Stock
SEC:0001310204-25-000011:0 · 15 Sept 2025
US$254,327 2,500 shares @ US$101.7307 0.0002% mcap 10.1% of flow
Common Stock
SEC:0001310204-25-000005 · 15 Aug 2025
€254,327 2,500 shares @ €101.7307 0.0002% mcap 5.1% of flow
Common Stock
SEC:0001310204-25-000005:0 · 15 Aug 2025
3,646 shares
Common Stock
SEC:0001127602-22-017336:0 · 10 Jun 2022
€16,045 348 shares @ €46.1073 0.0000% mcap 0.3% of flow
Common Stock
SEC:0001127602-22-011957:0 · 15 Feb 2022
768 shares
Common Stock
SEC:0001127602-22-009273:0 · 10 Mar 2022
01,817 shares 0
Common Stock
SEC:0001127602-22-003847 · 6 Feb 2022
01,817 shares 0
Common Stock
SEC:0001127602-22-003847:0 · 6 Feb 2022
019,020 shares 0
Common Stock
SEC:0001127602-22-002463 · 26 Jan 2022
019,020 shares 0
Common Stock
SEC:0001127602-22-002463:0 · 26 Jan 2022
1,913 shares
Common Stock
SEC:0001127602-21-029039 · 10 Nov 2021
1,913 shares
Common Stock
SEC:0001127602-21-029039:0 · 10 Nov 2021
25 of 29 declarations
Load more (4 remaining) About Dickinson Andrew D Andrew D Dickinson is the Chief Financial Officer of GILEAD SCIENCES, INC.